{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T09:51:08Z","timestamp":1787997068843,"version":"build-2784847793"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Catastrophic antiphospholipid syndrome is a rare variant of antiphospholipid syndrome where the presence of antiphospholipid antibodies and systemic inflammation leads to the rapid onset of multifocal thrombosis. Eosinophilia is known to accompany conditions such as allergy, parasite infection, malignancy, or autoimmune diseases; however, catastrophic antiphospholipid syndrome with eosinophilia has not been reported and its clinical influence remains unknown. We describe the first case of probable catastrophic antiphospholipid syndrome with eosinophilia, which mimicked eosinophil-associated disorders such as hypereosinophilic syndromes or eosinophilic granulomatosis with polyangiitis with disseminated intravascular coagulation, adding a new aspect of differential diagnosis of eosinophilia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A 46-year-old previously healthy Japanese man presenting with fever, abdominal pain, and skin lesions with pruritus showed marked eosinophilia, thrombocytopenia, and coagulopathy. A dynamic contrast-enhanced computed tomography scan of the abdomen showed some nonenhancing lesions in both lobes of the liver and the portal vein thrombosis. Upper gastrointestinal endoscopy showed gastric erosions, and lower gastrointestinal endoscopy revealed transverse colon and cecum ulcers. Common causes of eosinophilia including allergy, infection, and medication were not detected. He was initially suspected with hypereosinophilic syndromes or vasculitis such as eosinophilic granulomatosis with polyangiitis complicated by disseminated intravascular coagulation, and was treated with prednisone and thrombomodulin from hospital day 4 after bone marrow examination and the biopsies of the skin, stomach, and colon; however, these examinations excluded neoplastic hypereosinophilic syndromes and vasculitis. Later examination revealed positive antiphospholipid antibodies including lupus anticoagulant, anticardiolipin antibodies immunoglobulin G, and anticardiolipin \u03b22-glycoprotein 1 complex antibodies. He was complicated by colonic perforation and bilateral adrenal hemorrhage on day 10. Histopathology of the resected colon and liver biopsy confirmed arterial and venous small-vessel thrombosis and microthrombi, leading to the diagnosis of probable catastrophic antiphospholipid syndrome. He was successfully treated with plasma exchange and rituximab. He has been in remission of catastrophic antiphospholipid syndrome for 4 years, and his antiphospholipid antibodies have been negative post-rituximab treatment. His eosinophil count has been between normal to slightly increased, possibly due to the chronic adrenal insufficiency.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our case shows that eosinophilia can accompany catastrophic antiphospholipid syndrome, and this can mimic eosinophil-associated disorders with disseminated intravascular coagulation. Identifying antiphospholipid antibodies is important for differential diagnosis when treating unexplained eosinophilia, thrombocytopenia, and thrombosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13256-026-05851-0","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T12:33:51Z","timestamp":1770122031000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Catastrophic antiphospholipid syndrome with eosinophilia mimicking hypereosinophilic syndromes with disseminated intravascular coagulation: a case report"],"prefix":"10.1186","volume":"20","author":[{"given":"Hikari","family":"Ota","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Yoshizaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rintaro","family":"Wakamiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayano","family":"Matsunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Takeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Masuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"issue":"4","key":"5851_CR1","first-page":"508","volume":"19","author":"RA Asherson","year":"1992","unstructured":"Asherson RA. The catastrophic antiphospholipid syndrome. J Rheumatol. 1992;19(4):508\u201312.","journal-title":"J Rheumatol"},{"issue":"7","key":"5851_CR2","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1191\/0961203303lu394oa","volume":"12","author":"RA Asherson","year":"2003","unstructured":"Asherson RA, Cervera R, de Groot PG, et\u00a0al. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus. 2003;12(7):530\u20134.","journal-title":"Lupus"},{"issue":"3\u20134","key":"5851_CR3","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.jaut.2009.02.008","volume":"32","author":"R Cervera","year":"2009","unstructured":"Cervera R, Bucciarelli S, Plas\u00edn MA, et\u00a0al. Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the \u201cCAPS Registry.\u201d J Autoimmun. 2009;32(3\u20134):240\u20135.","journal-title":"J Autoimmun"},{"issue":"9","key":"5851_CR4","first-page":"481","volume":"15","author":"S Shiber","year":"2013","unstructured":"Shiber S, Yair M. Catastrophic antiphospholipid syndrome: a case series. Isr Med Assoc J. 2013;15(9):481\u20134.","journal-title":"Isr Med Assoc J"},{"issue":"4","key":"5851_CR5","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.pop.2016.07.010","volume":"43","author":"A Kovalszki","year":"2016","unstructured":"Kovalszki A, Weller PF. Eosinophilia. Prim Care. 2016;43(4):607\u201317.","journal-title":"Prim Care"},{"key":"5851_CR6","doi-asserted-by":"publisher","DOI":"10.4172\/2572-9462.1000103","volume":"2","author":"PRJ Ames","year":"2016","unstructured":"Ames PRJ, Merashli M, Graf M, Scarpato N, Arcaro A, Gentile F. Eosinophilia and antiphospholipid antibodies: double thrombogenic hits. A new case with a systematic review. J Thromb Circ. 2016;2: 103. https:\/\/doi.org\/10.4172\/2572-9462.1000103.","journal-title":"J Thromb Circ"},{"issue":"3","key":"5851_CR7","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s00281-021-00863-y","volume":"43","author":"P Valent","year":"2021","unstructured":"Valent P, Degenfeld-Schonburg L, Sadovnik I, et\u00a0al. Eosinophils and eosinophil-associated disorders: immunological, clinical, and molecular complexity. Semin Immunopathol. 2021;43(3):423\u201338. https:\/\/doi.org\/10.1007\/s00281-021-00863-y.","journal-title":"Semin Immunopathol"},{"issue":"12","key":"5851_CR8","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.autrev.2016.09.010","volume":"15","author":"I Rodr\u00edguez-Pint\u00f3","year":"2016","unstructured":"Rodr\u00edguez-Pint\u00f3 I, Moitinho M, Santacreu I, et\u00a0al. Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of 500 patients from the International CAPS Registry. Autoimmun Rev. 2016;15(12):1120\u20134.","journal-title":"Autoimmun Rev"},{"key":"5851_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00484","volume":"8","author":"NL Diny","year":"2017","unstructured":"Diny NL, Rose NR, \u010cih\u00e1kov\u00e1 D. Eosinophils in autoimmune diseases. Front Immunol. 2017;8: 484.","journal-title":"Front Immunol"},{"issue":"1","key":"5851_CR10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1177\/12034754211027858","volume":"26","author":"L Belmesk","year":"2022","unstructured":"Belmesk L, Muntyanu A, Cantin E, et\u00a0al. Prominent role of type 2 immunity in skin diseases: beyond atopic dermatitis. J Cutan Med Surg. 2022;26(1):33\u201349.","journal-title":"J Cutan Med Surg"},{"issue":"3","key":"5851_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9030303","volume":"9","author":"S Garcovich","year":"2021","unstructured":"Garcovich S, Maurelli M, Gisondi P, Peris K, Yosipovitch G, Girolomoni G. Pruritus as a distinctive feature of type 2 inflammation. Vaccines. 2021;9(3): 303.","journal-title":"Vaccines"},{"key":"5851_CR12","first-page":"61","volume":"17","author":"E Mouloudi","year":"2018","unstructured":"Mouloudi E, Katsanoulas K, Aslanidis TH, Lampiri CL, Papageorgiou CH, Tholioti TH. Eosinophilia: an early marker of adrenal insufficiency in critically ill patients with septic shock. Greek e J Perioper Med. 2018;17:61\u201370.","journal-title":"Greek e J Perioper Med."},{"issue":"3","key":"5851_CR13","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s42000-023-00463-5","volume":"22","author":"K Bouki","year":"2023","unstructured":"Bouki K, Venetsanaki V, Chrysoulaki M, et\u00a0al. Primary adrenal insufficiency due to bilateral adrenal hemorrhage-adrenal infarction in a patient with systemic lupus erythematosus and antiphospholipid syndrome: case presentation and review of the literature. Hormones. 2023;22(3):521\u201331.","journal-title":"Hormones"},{"issue":"5","key":"5851_CR14","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1002\/ame2.12277","volume":"5","author":"WJ Xu","year":"2022","unstructured":"Xu WJ, Wang S, Yuan P, Wang L, Huang JX, Jiang R. Arterial and venous thromboembolism risk associated with blood eosinophils: a systematic review and meta-analysis. Anim Model Exp Med. 2022;5(5):470\u201381.","journal-title":"Anim Model Exp Med"},{"key":"5851_CR15","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/9095275","volume":"2018","author":"GA Ramirez","year":"2018","unstructured":"Ramirez GA, Yacoub MR, Ripa M, et\u00a0al. Eosinophils from physiology to disease: a comprehensive review. Biomed Res Int. 2018;2018: 9095275. https:\/\/doi.org\/10.1155\/2018\/9095275.","journal-title":"Biomed Res Int"},{"issue":"4","key":"5851_CR16","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1080\/17474086.2017.1300522","volume":"10","author":"O Carmi","year":"2017","unstructured":"Carmi O, Berla M, Shoenfeld Y, Levy Y. Diagnosis and management of catastrophic antiphospholipid syndrome. Expert Rev Hematol. 2017;10(4):365\u201374.","journal-title":"Expert Rev Hematol"},{"issue":"5","key":"5851_CR17","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1002\/ajh.27287","volume":"99","author":"W Shomali","year":"2024","unstructured":"Shomali W, Gotlib J. World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management. Am J Hematol. 2024;99(5):946\u201368.","journal-title":"Am J Hematol"},{"issue":"3","key":"5851_CR18","doi-asserted-by":"publisher","first-page":"161","DOI":"10.4168\/aair.2012.4.3.161","volume":"4","author":"SM Park","year":"2012","unstructured":"Park SM, Park JW, Kim SM, et\u00a0al. A case of hypereosinophilic syndrome presenting with multiorgan infarctions associated with disseminated intravascular coagulation. Allergy Asthma Immunol Res. 2012;4(3):161\u20134.","journal-title":"Allergy Asthma Immunol Res"},{"issue":"1","key":"5851_CR19","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4103\/ctm.ctm_3_19","volume":"5","author":"M Abdulla","year":"2019","unstructured":"Abdulla M. Idiopathic hypereosinophilic syndrome and disseminated intravascular coagulation. Cancer Transl Med. 2019;5(1):22\u20133.","journal-title":"Cancer Transl Med"},{"issue":"5","key":"5851_CR20","doi-asserted-by":"publisher","first-page":"670","DOI":"10.2174\/157016112801784594","volume":"10","author":"A Maino","year":"2012","unstructured":"Maino A, Rossio R, Cugno M, Marzano AV, Tedeschi A. Hypereosinophilic syndrome, Churg-Strauss syndrome and parasitic diseases: possible links between eosinophilia and thrombosis. Curr Vasc Pharmacol. 2012;10(5):670\u20135.","journal-title":"Curr Vasc Pharmacol"},{"issue":"3","key":"5851_CR21","doi-asserted-by":"publisher","first-page":"234","DOI":"10.7861\/clinmed2023-0076","volume":"23","author":"J Schofield","year":"2023","unstructured":"Schofield J, Toh CH. How to approach acute thrombosis and thrombocytopenia. Clin Med. 2023;23(3):234\u201341.","journal-title":"Clin Med"},{"issue":"10","key":"5851_CR22","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1002\/art.41891","volume":"73","author":"D Erkan","year":"2021","unstructured":"Erkan D. Expert perspective: management of microvascular and catastrophic antiphospholipid syndrome. Arthritis Rheumatol. 2021;73(10):1780\u201390.","journal-title":"Arthritis Rheumatol"},{"issue":"11 Pt 2","key":"5851_CR23","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.lpm.2019.10.003","volume":"48","author":"I Rodr\u00edguez-Pint\u00f3","year":"2019","unstructured":"Rodr\u00edguez-Pint\u00f3 I, Lozano M, Cid J, Espinosa G, Cervera R. Plasma exchange in catastrophic antiphospholipid syndrome. Presse Med. 2019;48(11 Pt 2):347\u201353.","journal-title":"Presse Med"},{"issue":"11","key":"5851_CR24","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.autrev.2013.05.004","volume":"12","author":"H Berman","year":"2013","unstructured":"Berman H, Rodr\u00edguez-Pint\u00f3 I, Cervera R, et\u00a0al. Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab. Autoimmun Rev. 2013;12(11):1085\u201390.","journal-title":"Autoimmun Rev"},{"issue":"1","key":"5851_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2016-000182","volume":"4","author":"B Gracia-Tello","year":"2017","unstructured":"Gracia-Tello B, Ezeonyeji A, Isenberg D. The use of rituximab in newly diagnosed patients with systemic lupus erythematosus: long-term steroid saving capacity and clinical effectiveness. Lupus Sci Med. 2017;4(1): e000182.","journal-title":"Lupus Sci Med."},{"issue":"6","key":"5851_CR26","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/j.jaip.2017.08.001","volume":"5","author":"FL Kuang","year":"2017","unstructured":"Kuang FL, Klion AD. Biologic agents for the treatment of hypereosinophilic syndromes. J Allergy Clin Immunol Pract. 2017;5(6):1502\u20139.","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-026-05851-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-026-05851-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-026-05851-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T10:30:06Z","timestamp":1772620206000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13256-026-05851-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5851"],"URL":"https:\/\/doi.org\/10.1186\/s13256-026-05851-0","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]},"assertion":[{"value":"29 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This case report was approved by the institutional Review Board (including ethical approval) at Mishuku Hospital, Tokyo, Japan.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"127"}}